Privia Health Group, Inc. (NASDAQ: PRVA) reported Q2 EPS of $0.19, $0.12 better than the analyst estimate of $0.07. Revenue for the quarter came in at $632.6 million versus the consensus estimate of $597.76 million.

FY2026 Outlook-

Revenue between $2.35 billion to 2.45 billion versus the consensus $2.42 billion.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.